Atai Life Sciences Income Taxes 2020-2024 | ATAI
Atai Life Sciences income taxes from 2020 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
| Atai Life Sciences Annual Income Taxes (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $1 |
| 2022 | $6 |
| 2021 | $-4 |
| 2020 | $0 |
| 2019 | $0 |
| Atai Life Sciences Quarterly Income Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $6 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.294B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $18.282B | 18.36 |
| DaVita (DVA) | United States | $11.202B | 14.29 |
| Encompass Health (EHC) | United States | $10.408B | 23.33 |
| Chemed (CHE) | United States | $8.501B | 27.28 |
| Option Care Health (OPCH) | United States | $5.259B | 25.21 |
| Elanco Animal Health (ELAN) | United States | $4.190B | 9.27 |
| RadNet (RDNT) | United States | $3.686B | 79.02 |
| Amedisys (AMED) | United States | $3.011B | 21.29 |
| LifeStance Health (LFST) | United States | $2.576B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.840B | 21.32 |
| Astrana Health (ASTH) | United States | $1.573B | 35.26 |
| U.S Physical Therapy (USPH) | United States | $1.025B | 26.14 |
| Pennant (PNTG) | United States | $0.907B | 36.29 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.886B | 0.00 |
| Daxor (DXR) | United States | $0.036B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |